Clinical trial Recruiting at 1 site Observational Ages 18 and up

Simultaneous carotid artery stenting and cardiac surgery for high-risk patients

Official title: SIMultaneous Urgent Cardiac Surgery and Endovascular Stroke Prevention Using the Micronet-covered CGUARD Stent in Hemodynamically Compromised Patients at Increased Peri-operative Stroke Risk: SIM-GUARD Study

Run by John Paul II Hospital, Krakow · NCT04973579 · Data updated 2026-11-12

This study tests if doing carotid artery stenting at the same time as heart surgery can help high-risk patients with both conditions recover better and have fewer complications.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorJohn Paul II Hospital, Krakow
Academic / other
Locations1 site (Krakow)
StatusRecruiting
StartedMay 1, 2021
Main results expectedMay 1, 2022
Study endsMay 1, 2027
Registry record updatedJuly 22, 2021
Trial IDNCT04973579 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with symptomatic carotid stenosis and unstable coronary artery disease or severe valvular heart disease requiring urgent surgical intervention.

Probably not a fit

Patients who are asymptomatic with carotid stenosis less than 50% or those without significant cardiac conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical registry focuses on patients with symptomatic carotid artery stenosis who also have severe coronary artery disease or valvular heart disease requiring urgent surgery. It evaluates the outcomes of performing carotid revascularization using a mesh stent simultaneously with cardiac surgery under a single anesthesia. The study aims to address the high risks associated with sequential treatments by implementing a single-stage procedure that combines both interventions. Patients will be monitored for long-term outcomes following this innovative approach.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of stroke and cardiac complications in high-risk patients undergoing simultaneous procedures.

How similar studies have gone: While similar approaches have been explored, this specific simultaneous treatment strategy is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients eligible for concomitant carotid artery stenting in conjunction with cardiac surgery based on Heart Team and NeuroVascular Team reccomendation and according to local standards of practice.
* Signed informed consent form
* Consent to (routinely performed in this group of patients) follow-up visits and tests performed (routinely) during long-term follow-up
* De novo atherosclerotic lesions or neo-atherosclerosis.
* Symptomatic patients (with a history of ipsilateral transient cerebral ischemia, stroke or amaurosis fugax within the past 6 months) with carotid artery stenosis ≥50% as assessed by NASCET angiography or
* Asymptomatic patients with carotid artery stenosis ≥70-80% as assessed by angiography (NASCET method).
* Coronary angiography-confirmed multivessel disease or left main stem stenosis with the symptoms of unstable angina or non-ST-segment elevation myocardial infarction.
* Severe symptomatic valvular disease detected by echocardiography.

Exclusion Criteria:

* Expected survival time \<1 year (e.g., cancer).
* Renal failure with GFR \< 20 ml/min/1.73 m2 as calculated by the CKD-EPI formula
* Women who are pregnant (pregnancy test).
* Coagulopathies.
* History of hypersensitivity to a contrast agent that does not respond to pharmacotherapy.
* Total carotid artery occlusion.
* Stent in the carotid artery that protrudes into the aortic arch.
* Anatomic variants that preclude stent implantation.
* Significant stenosis of the common carotid artery proximal to the target lesion.
* Mobile atherosclerotic plaques in the aortic arch.
* Anatomy of the coronary arteries unsuitable for bypass grafting.
* Lack of available vascular material for grafting.
* Porcelain aorta.

Where it's running

  • Department of Cardiac and Vascular Diseases, John Paul II Hospital
    Krakow, Poland
    Recruiting

Study contacts

  • Principal investigator: Piotr Musialek, MD, DPhil — Department of Cardiac and Vascular Diseases, John Paul II Hospital
  • Study coordinator: Piotr Musialek, MD, DPhil
  • Email: pmusialek@szpitaljp2.krakow.pl
  • Phone: +48126142287

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.